EVRE
ActiveSummary
EVRE has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €208,397 and a net result of €11,762. Equity has been growing by about 44% per year since 2022. Its solvency ranks better than 92% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 24-05-2022 Normal situation
- Activity
- General medical practice NACE 86210
- Joint committee
- 330.04 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2023
- Establishment unit
- 2.332.152.786 2060 Antwerpen, since 24-05-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 12-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €25,713
- ▼ 79.5%
- Turnover
- ≈ €79,000
- estimated
- Profit
- €11,762
- ▼ 86.1%
- Equity
- €208,397
- ▲ 6.0%
- Total assets
- €218,793
- ▼ 34.6%
- 2025 accounts filed 60 days after the deadline
Score breakdownraises riskLast filed accounts filed 60 days late; 1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 11.56, cash €105,849Equity €208,397 (95.2% of total assets)Show the evidence
Checked score
Score 2025
95
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 58% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency
100+16
equity 95.2% of total assets
Liquidity
100+24
short-term debt 4.8% · cash 48.4%
Profitability
51-49
return on assets 5.4%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: 0.1%▲ +0.1 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025highest value
10-2025: < 0.1%▼ -0.1 percentage points vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026lowest value
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: 0.1%▲ +0.1 percentage points vs 08-2026
10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €19,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 11.56 (1.66 in 2024), above the usual 1.5. Short-term debt is 4.8% and cash 48.4% of total assets. 4.8% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 8% on profitability and 47% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 60 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-09-2026, 60 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filingsDeviation from the deadline
2025
60 days late
2024
28 days late
2023
5 days early
2022
4 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 20 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 12 August (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, micro format
2025 annual accounts filed 60 days after the deadline Filed on 29 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00530502.
Annual accounts 2025 filed on 29-09-2026 at the NBB all 4 filings
Turnover
≈ €79,000
Estimated: probably between €57,000 and €110,000
Total assets
€218,793▼ 34.6%
2024 · €334,547
Net result
€11,762▼ 86.1%
2024 · €84,805
Working capital
€109,813▲ 20.6%
2024 · €91,052
Multi-year overview
2022 to 2025, 4 financial yearsOperating result
€16,963
▼ 85.4%
2025
20222025
Net result
€11,762
▼ 86.1%
2025
lowest quarter of the sector
20222025
Equity
€208,397
▲ 6.0%
2025
middle half of the sector
20222025
Total assets
€218,793
▼ 34.6%
2025
middle half of the sector
20222025
Debt
€10,396
▼ 92.5%
2025
20222025
Working capital
€109,813
▲ 20.6%
2025
middle half of the sector
20222025
Solvency
95.2%
▲ 36.5pp
2025
highest quarter of the sector
20222025
Current ratio
11.56
▲ 9.90
2025
highest quarter of the sector
20222025
Return on assets (ROA)
5.4%
▼ 20.0pp
2025
lowest quarter of the sector
20222025
Staff (FTE)
no figure
2025
20222025
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line2022202320242025
Operating result€43,625-€108,205▲ 148%€116,002▲ 7.2%€16,963▼ 85.4%
Net result€31,622within the sector's middle half-€76,608within the sector's middle half▲ 142%€84,805within the sector's middle half▲ 10.7%€11,762below the sector's middle half▼ 86.1%
Equity€35,222below the sector's middle half-€111,830within the sector's middle half▲ 217%€196,635within the sector's middle half▲ 75.8%€208,397within the sector's middle half▲ 6.0%
Total assets€47,542below the sector's middle half-€264,698within the sector's middle half▲ 457%€334,547within the sector's middle half▲ 26.4%€218,793within the sector's middle half▼ 34.6%
Debt€12,319-€152,868▲ 12×€137,912▼ 9.8%€10,396▼ 92.5%
Working capital€35,006within the sector's middle half-€1,797below the sector's middle half▼ 94.9%€91,052within the sector's middle half▲ 51×€109,813within the sector's middle half▲ 20.6%
Solvency74.1%within the sector's middle half-42.2%within the sector's middle half▼ 31.8pp58.8%within the sector's middle half▲ 16.5pp95.2%above the sector's middle half▲ 36.5pp
Current ratio4.17within the sector's middle half-1.01below the sector's middle half▼ 3.151.66within the sector's middle half▲ 0.6511.56above the sector's middle half▲ 9.90
Return on assets (ROA)66.5%above the sector's middle half-28.9%within the sector's middle half▼ 37.6pp25.3%within the sector's middle half▼ 3.6pp5.4%below the sector's middle half▼ 20.0pp
Staff (FTE)1-1.7▲ 70.0%
above
within
below
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2025 is 85% lower than in 2024 and the lowest since 2022.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €218,793
Fixed assets
€98,583 ▼ 6.6%
Current assets
€120,209 ▼ 47.5%
Equity and liabilities €218,793
Equity
€208,397 ▲ 6.0%
Debt
€10,396 ▼ 92.5%
Debt's share of the balance-sheet total falls from 41.2% to 4.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€23,963▼
2024 · €123,002
Cash flow
€18,762▼
2024 · €91,805
Debt to equity
0.05▼
2024 · 0.70
ROE
5.6%▼
2024 · 43.1%
Interest coverage
3.01▼
2024 · 38.31
Debt ≤ 1 year
€10,396▼
2024 · €137,912
Income taxes
€3,921▼
2024 · €31,245
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Staff
| Item | 31-12-2022 | 31-12-2023 |
|---|---|---|
| Employees at the balance-sheet date | 1 | 0 |
| full-time | - | 0 |
| part-time | 1 | 0 |
| in full-time equivalents | 0.5 | 0 |
| Average over the year, in full-time equivalents | 0.7 | 0.9 |
| On a permanent contract | 1 | 0 |
| Joined | 4 | 9 |
| Left | 3 | 10 |
| Training hours | - | 0 |
Source: social balance sheet in the 2022 to 2023 annual accounts
Investments
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Tangible fixed assets | €1,972 | €119,000 | - | - |
| Depreciation and write-downs of the year | €493 | €6,417 | €7,000 | €7,000 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €18,133 | €0 | - | - |
| Remuneration, social security and pensions62 | €20,267 | €57,564 | €143 | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €493 | €6,417 | €7,000 | €7,000 | = |
| Other operating charges640/8 | €833 | €17,464 | €2,155 | €1,750 | ▼ 18.8% |
| Non-recurring operating charges66A | €196 | €0 | - | - | - |
| Gross operating margin9900 | €65,414 | €189,649 | €125,301 | €25,713 | ▼ 79.5% |
| Operating profit (loss)9901 | €43,625 | €108,205 | €116,002 | €16,963 | ▼ 85.4% |
| Financial income75/76B | - | €411 | €3,258 | €6,683 | ▲ 105% |
| Recurring financial income75 | - | €411 | €3,258 | €6,683 | ▲ 105% |
| Financial charges65/66B | €137 | €2,903 | €3,210 | €7,964 | ▲ 148% |
| Recurring financial charges65 | €137 | €2,903 | €3,210 | €7,964 | ▲ 148% |
| Profit (loss) for the period before taxes9903 | €43,488 | €105,713 | €116,049 | €15,682 | ▼ 86.5% |
| Income taxes67/77 | €11,865 | €29,105 | €31,245 | €3,921 | ▼ 87.5% |
| Profit (loss) for the period9904 | €31,622 | €76,608 | €84,805 | €11,762 | ▼ 86.1% |
| Profit (loss) for the period to be appropriated9905 | €31,622 | €76,608 | €84,805 | €11,762 | ▼ 86.1% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €47,542 | €264,698 | €334,547 | €218,793 | ▼ 34.6% |
| Fixed assets21/28 | €1,479 | €112,583 | €105,583 | €98,583 | ▼ 6.6% |
| Tangible fixed assets22/27 | €1,479 | €112,583 | €105,583 | €98,583 | ▼ 6.6% |
| Land and buildings22 | - | €112,583 | €105,583 | €98,583 | ▼ 6.6% |
| Plant, machinery and equipment23 | €1,479 | €0 | - | - | - |
| Current assets29/58 | €46,062 | €152,115 | €228,963 | €120,209 | ▼ 47.5% |
| Amounts receivable within one year40/41 | €35,993 | €78,646 | €105,904 | €14,361 | ▼ 86.4% |
| Other amounts receivable41 | €35,993 | €78,646 | €105,904 | €14,361 | ▼ 86.4% |
| Cash at bank and in hand54/58 | €2,077 | €70,618 | €123,060 | €105,849 | ▼ 14.0% |
| Deferred charges and accrued income490/1 | €7,993 | €2,851 | €0 | - | - |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €47,542 | €264,698 | €334,547 | €218,793 | ▼ 34.6% |
| Equity10/15 | €35,222 | €111,830 | €196,635 | €208,397 | ▲ 6.0% |
| Contributions10/11 | €3,600 | €3,600 | €3,600 | €3,600 | = |
| Reserves13 | €31,622 | €108,230 | €193,035 | €204,797 | ▲ 6.1% |
| Distributable reserves133 | €31,622 | €108,230 | €193,035 | €204,797 | ▲ 6.1% |
| Amounts payable17/49 | €12,319 | €152,868 | €137,912 | €10,396 | ▼ 92.5% |
| Amounts payable within one year42/48 | €11,057 | €150,318 | €137,912 | €10,396 | ▼ 92.5% |
| Trade debts44 | €5,714 | €454 | €12,146 | - | - |
| Suppliers440/4 | €5,714 | €454 | €12,146 | - | - |
| Taxes, remuneration and social security45 | €5,343 | €11,976 | €9,244 | €10,396 | ▲ 12.5% |
| Taxes450/3 | €3,162 | €8,422 | €9,244 | €10,396 | ▲ 12.5% |
| Remuneration and social security454/9 | €2,181 | €3,554 | €0 | - | - |
| Other amounts payable47/48 | - | €137,888 | €116,522 | - | - |
| Accrued charges and deferred income492/3 | €1,263 | €2,550 | €0 | - | - |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €31,622 | €76,608 | €84,805 | €11,762 | ▼ 86.1% |
| + Depreciation and write-downs630 | €493 | €6,417 | €7,000 | €7,000 | = |
| Operating cash flow (approximation) | €32,116 | €83,024 | €91,805 | €18,762 | ▼ 79.6% |
| Investment in fixed assets (approximation) | - | -€117,521 | €0 | €0 | - |
| Change in cash | - | €68,541 | €52,442 | -€17,211 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 39,278 companies had the same profile as EVRE has now. Two years later, 95.9% were still going and 1.8% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
95.9%
was still going
2.3%
stopped otherwise
1.8%
went bankrupt
The bankruptcy probability of EVRE itself is lower: < 0.1% within 12 months. It rests on far more data about EVRE than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for EVRE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Board & ownership
Directors
Directors
1 director, no change since 2022
VAN REUSEL Elly Beppy Irene
Current
Director · since 24-05-2022 · term without a fixed end · listed in the 2025 annual accounts, filed on 29-09-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Artikel 13. Bevoegdheden van het bestuursorgaan Eén bestuurder Als er slechts één bestuurder is, is het geheel van de bevoegdheden van de…”
deed of 27-05-2022Owners and capital
Shareholders
At incorporation
act of 27-05-2022 ↗
- VAN REUSEL Elly Beppy Irene 120 shares (100%) · €3,600 in cash
Capital transactions
Capital over time
- 27-05-2022 Incorporation · €3,600 · 120 shares
Network & group
EVRE shares no director with another company.
Companies at the same address
1 other companyConnections & network
1 current directorThe network starts from the directors of EVRE. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
29-09
micro format · 60 days late
2025
31-12
Financial
Weakest financial yearnet €11,762 ▼86.1%
The net result drops to €11,762, the lowest from 2022 to 2025.
31-12
Financial
Liquidity more than 6 timescurrent ratio 11.56
The current ratio rises from 1.66 to 11.56. Short-term debt falls from €137,912 to €10,396.
31-12
Financial
Equity above €200,000equity €208,397 ▲6%
With a profit in every financial year since 2022, equity grows to €208,397.
28-08
micro format · 28 days late
2024
31-12
Financial
Highest result from 2022 to 2025net €84,805 ▲10.7%
The operating result of €116,002 and the net result of €84,805 are both a record.
31-12
Financial
Equity above €150,000equity €196,635 ▲75.8%
With a profit in every financial year since 2022, equity grows to €196,635.
26-07
micro format · 5 days before the deadline
2023
31-12
Financial
Equity above €100,000equity €111,830 ▲217%
With a profit in every financial year since 2022, equity grows to €111,830.
27-07
micro format · 4 days before the deadline
2022
27-05
Gazette deed
IncorporationStarting capital €3,600 · Appointment: VAN REUSEL Elly Beppy Irene (director) · Founder8 points ▸
Gazette deed
Incorporation
Starting capital €3,600 · Appointment: VAN REUSEL Elly Beppy Irene (director) · Founder8 points ▸
- Incorporation, 20-05-2022
- Founder, VAN REUSEL Elly Beppy Irene
- Founding capital, €3,600
- Other provision, “dag neerlegging uittreksel ter griffie, Verkrijging rechtspersoonlijkheid” (deed in Dutch)
- Registered office clause, “Pothoekstraat 113,2060 Antwerpen” (deed in Dutch)
- Board rule, 1, “vergadering” (deed in Dutch)
- Director appointment, VAN REUSEL Elly Beppy Irene (director)
- Pre-incorporation commitments, “takeover, activiteiten en verbintenissen en verplichtingen in naam en voor rekening van vennootschap in oprichting” (deed in Dutch)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
EVRE in Dutch
Enterprise number
0786.488.074
Legal form
Private limited company
Status
Active, normale toestand
Founded
24-05-2022
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 27-05-2022 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Voorzover geen wijziging taalregime, Vlaamse Gewest”
deed of 27-05-2022 (in Dutch)Registered office and establishments
Registered office
Pothoekstraat 113, 2060 Antwerpen, Belgium
Establishment unit
Evre, Pothoekstraat 113, 2060 Antwerpen since 24-05-2022 · unit number 2.332.152.786
Activities
NACEBEL 202586210
General medical practice main activity
Codes under NACEBEL 2008
86210
General medical practice main activity
Joint committee
330.04 Paritair Comité voor de gezondheidsinrichtingen en -diensten annual accounts 2023
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 27-05-2022 (in Dutch)
“De uitoefening van de geneeskunde met specialisatie ‘huisartsgeneeskunde’ door de geneesheren-vennoten in naam en voor rekening van de…”
8 activities
- De uitoefening van de geneeskunde met specialisatie ‘huisartsgeneeskunde’ door de geneesheren-vennoten in naam en voor rekening van de vennootschap,met inachtname van de regels van de geneeskundige plichtenleer en met inachtname van de normale vergoeding voor het door de geneesheren-vennoten gepresteerde werk,ongeacht de verdeling van de aandelen
- De geneesheren-vennoten,die allen lid dienen te zijn van de Orde van Geneesheren,brengen hun volledige medische activiteit in gemeenschap en de daaruit volgende honoraria zullen geïnd worden door en voor de vennootschap
- De vennootschap kan bovendien alle werkzaamheden en rechtshandelingen verrichten die van aard zijn rechtstreeks de verwezenlijking van haar voorwerp te bevorderen
- De vennootschap mag deelnemen aan alle ondernemingen die een gelijkaardig voorwerp nastreven
- Daartoe kan de vennootschap samenwerken met,deelnemen in,of op gelijk welke wijze,rechtstreeks of onrechtstreeks,belangen nemen in andere ondernemingen
- De vennootschap kan zowel tot waarborg van eigen verbintenissen als tot waarborg van verbintenissen van derden borg stellen,onder meer door haar goederen in hypotheek of in pand te geven,inclusief de eigen handelszaak
- De vennootschap kan eveneens optreden als bestuurder,volmachtdrager,mandataris of vereffenaar in andere vennootschappen of ondernemingen
- De vennootschap kan in het algemeen alle commerciële,industriële,financiële,roerende of onroerende handelingen verrichten in rechtstreeks of onrechtstreeks verband met haar voorwerp of welke van aard zouden zijn de verwezenlijking ervan geheel of ten dele te vergemakkelijken
Invoicing and payment
VAT number
BE 0786.488.074
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of June at 20:00
deed of 27-05-2022 (in Dutch)Sites & property
Location
Buildings and parcels at the address
Ground area
1,385 m²
Building footprint
1,118 m²
Building volume
15,383 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 11805E0413/00N011 | Flanders | 1,385 m² | 1 · 1,118 m² | 20.9 m · 5 |